BioWorld-International-2007-03-28
Algeta Grosses $41M In IPO To Advance Alpharadin Trials
Algeta Grosses $41M In IPO To Advance Alpharadin Trials
Algeta ASA's IPO on the Oslo Stock Exchange hit the upper end of its target, raising gross proceeds of slightly less than NOK250 million (US$41.1 million). (BioWorld International)

